Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Genius Sports (GENI) Cash & Equivalents (2019 - 2025)

Genius Sports' Cash & Equivalents history spans 7 years, with the latest figure at $280.6 million for Q4 2025.

  • For the quarter ending Q4 2025, Cash & Equivalents rose 154.56% year-over-year to $280.6 million, compared with a TTM value of $280.6 million through Dec 2025, up 154.56%, and an annual FY2025 reading of $280.6 million, up 154.56% over the prior year.
  • Cash & Equivalents for Q4 2025 was $280.6 million at Genius Sports, up from $110.2 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $280.6 million in Q4 2025, with the low at $100.3 million in Q4 2023.
  • Average Cash & Equivalents over 5 years is $167.2 million, with a median of $122.7 million recorded in 2022.
  • Year-over-year, Cash & Equivalents soared 1787.6% in 2021 and then plummeted 44.82% in 2022.
  • Tracing GENI's Cash & Equivalents over 5 years: stood at $222.4 million in 2021, then plummeted by 44.82% to $122.7 million in 2022, then decreased by 18.24% to $100.3 million in 2023, then increased by 9.85% to $110.2 million in 2024, then skyrocketed by 154.56% to $280.6 million in 2025.
  • Per Business Quant, the three most recent readings for GENI's Cash & Equivalents are $280.6 million (Q4 2025), $110.2 million (Q4 2024), and $100.3 million (Q4 2023).